**Praziquantel and Arachidonic Acid Combination — An Innovative Approach to the Treatment of Schistosomiasis**

Hatem Tallima, Kevin Hadley and Rashika El Ridi

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/61185

#### **Abstract**

Schistosomiasis is a debilitating disease caused by trematode worms of the genus *Schistosoma*. Three members *Schistosoma mansoni*, *Schistosoma haematobium*, and *Schistosoma japonicum* are responsible for the great majority of human infections. Schistosomiasis is widespread in sub-Saharan Africa, several countries of the Mid‐ dle East, South America, and South-East Asia. Vaccination against the infection would be the most reliable way to combat the infection and decrease or interrupt its transmission, but a commercial vaccine is still unavailable. Praziquantel (PZQ) is the only drug considered for schistosomiasis treatment as it is effective against the major human schistosomes, commercially available, cost-affordable, and elicits lim‐ ited side-effects. Several reports documented the highly significant PZQ efficacy in treatment of light infections in areas of low *S. mansoni* and *S. haematobium* endemici‐ ty and PZQ use. Chemotherapy with PZQ alone of patients residing in regions of high schistosome endemicity and afflicted with light, moderate, or heavy infection is not efficacious. Accordingly, we propose implementation of cost-affordable arachidonic acid (ARA), a polyunsaturated omega-6 fatty acid and efficacious in vi‐ tro and in vivo schistosomicide, for oral therapy of children with *Schistosoma manso‐ ni* and *Schistosoma haematobium* light infection, as adjunct to PZQ for cure of children with moderate and heavy infections, and for counteracting schistosome re‐ sistance to PZQ that arises in endemic areas exposed to repeated and intense PZQ mass treatment campaigns.

**Keywords:** Praziquantel, Arachidonic acid, Schistosomiasis, Chemotherapy, Com‐ bination chemotherapy

© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
